Ken Fisher Concert Pharmaceuticals, Inc. Transaction History

Fisher Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 24, 2018	SELL	$12.82 - $17.88 $202,094 - $281,860	-15,764 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$16.83 - $21.66 $994,232 - $1.28 Million	-59,075 Reduced 78.94%	15,764 $265,000
Q1 2018 May 11, 2018	SELL	$19.24 - $28.03 $613,717 - $894,100	-31,898 Reduced 29.88%	74,839 $1.71 Million
Q1 2018 Apr 19, 2018	BUY	$19.24 - $28.03 $613,717 - $894,100	31,898 Added 42.62%	106,737 $2.44 Million
Q3 2017 Oct 17, 2017	BUY	$13.91 - $15.31 $1.04 Million - $1.15 Million	74,839	74,839 $1.1 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.